// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Audit of the need and access to dental services in inflammatory arthritis patients

Zoe Rutter-Locher - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

The scope of rheumatology services in a large urban district general hospital

Alastair Green - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Radiation (yttrium) synovectomy at Freeman Hospital, Newcastle-upon-Tyne 2015-2017: a review of practice and patient experience

Hanaa Rajabally - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Does comorbidity adversely impact upon treatment response in patients with rheumatoid arthritis? A retrospective analysis of routine care data

Catherine Hughes - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Biologic monotherapy in rheumatoid arthritis: a retrospective observational study of real life practice in the North West

Rosalind Benson - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Tocilizumab

Exploring the impact of health status and capability of people with inflammatory arthritis on presenteeism in the workplace: a qualitative study

Cheryl J Jones - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Point of care testing for CRP

Sardar Bahadur - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Factors associated with oral specialist referral of patients with Sjögren’s syndrome in a rheumatology tertiary centre

Gavriella Levinson - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Sjogren's syndrome

N/A

The assessment and management of psoriasis in people with psoriatic arthritis onbiologic drugs: adherence to NICE guidelines

Kerry Jobling - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ankylosing spondylitis

golimumab

Audit of apremilast for psoriatic arthritis: experience from an 18-month local patient access scheme

Matthew Chak Hin Szeto - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

Apremilast

Don’t think outside the box! Get rid of the box: a case of polyangitis with granulomatosis presenting as a pericardial effusion

Iman Ali - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Cyclophosphamide

Moderate to good construct validity of global presenteeism measures with multi-item presenteeism measure and patient-reported health outcomes

Sarah Leggett - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Clinical phenotypes of patients with rheumatoid arthritis who identify as in a patient acceptable symptom state at methotrexate initiation and a comparison of the outcome of these phenotypes over 12 months

James Gwinnutt - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Rheumatoid arthritis

Methotrexate

Does the implementation of a physiotherapist into an early arthritis clinic alter the accuracy of patient assessment?

Rhys Hayward - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Predicting pelvic fractures using bone mineral density in the lumbar spine and femoral neck: a case-control study

Kristen Davies - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Predictors of site of fracture in patients with history of parental fracture

Mrinalini Dey - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Giant cell arteritis

Medroxyprogesterone

Do patients with fibromyalgia place increased demands on healthcare resources?

Miriam Bennett - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Post traumatic stress disorder

N/A

Corticosteroid injections for shoulder pain in primary care: patient characteristics, management and timing of referral

Luke Sammut - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Joint injection consent in rheumatology: a clinical audit

Edmond T Quah - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

UK Rheumatologist in Training Network: results from first national multi-site audit: documentation and consent for intra-articular and soft tissue injection (IAI)

Laura R Newton - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

N/A

Copyright © 2026. QuantiNova All rights reserved